Intensive Care News and Research

RSS

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

In a recent prospective study published in the Annals of Internal Medicine Journal, researchers in the United States (US) and Spain performed a randomized controlled trial (RCT) across 127 US hospitals between 2021 and 2022.

27 Mar 2023

High-resolution mass spectrometric rapid identification of Candida auris

A recent study published in the Journal of Fungi used a novel OrbitrapTM high-resolution mass spectrometric technology coupled with liquid chromatography to identify geographically different clades of Candida auris (C. auris) isolates. This proof-of-concept methodology could accurately detect C. auris in the microbiology laboratory.

23 Mar 2023

Study reveals the risk factors associated with developing long Covid

Being vaccinated against Covid halves people's risk of developing long Covid, according to new research from the University of East Anglia.

23 Mar 2023

Dampened mucosal response against SARS-CoV-2 in pregnant individuals

In a recent study posted to the medRxiv* preprint server, researchers examined associations between coronavirus disease 2019 (COVID-19) outcomes and mucosal antibody responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and viral RNA levels in pregnant individuals.

22 Mar 2023

End of covid emergency will usher in changes across the US health system

The Biden administration's decision to end the covid-19 public health emergency in May will institute sweeping changes across the health care system that go far beyond many people having to pay more for covid tests.

22 Mar 2023

Paxlovid is 80% effective when taken within 5 days of severe COVID

In a recent study published in The Lancet’s Infectious Diseases, researchers in the United States evaluated nirmatrelvir–ritonavir treatment effectiveness against hospitalizations and deaths among coronavirus disease 2019 (COVID-19) outpatients in the United States of America (USA).

21 Mar 2023

The effectiveness of mRNA vaccines during Omicron BA.4/5 predominance

Researchers evaluate vaccine effectiveness for two, three, and four doses of COVID-19 mRNA first-generation vaccines.

21 Mar 2023

Co-infection with MRSA ‘superbug’ could make COVID-19 outcomes even more deadly

Global data shows nearly 10 per cent of severe COVID-19 cases involve a secondary bacterial co-infection – with Staphylococcus aureus, also known as Staph A., being the most common organism responsible for co-existing infections with SARS-CoV-2.

21 Mar 2023

People conceived by IVF are not at increased risk of obstetric or perinatal complications, study finds

There's little evidence to suggest that children conceived as a result of fertility treatment are at any greater risk of pregnancy complications or worse birth outcomes than their naturally conceived peers, finds a long-term study, published in the open access journal BMJ Medicine.

21 Mar 2023

Poor inflammatory immune response in obese patients increases susceptibility to severe COVID-19

Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response, say Cambridge scientists.

20 Mar 2023

Study confirms the benefit of Paxlovid as an early-stage treatment to prevent COVID-19 hospitalization

A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless of prior immunity or age.

17 Mar 2023

Real-world data on the effectiveness of Sotrovimab as a prophylactic against COVID-19

In a recent study posted in the medRxiv* preprint server, scientists assessed the efficacy of sotrovimab for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) treatment.

16 Mar 2023

Study implicates gut microbiome and immune response in hospital-acquired infections

In a recent study published in the journal Nature Medicine, researchers at the University of Calgary analyzed the dynamics of fecal microbiota and conducted single-cell profiling of inflammatory responses and systemic immunity to determine associations between gut microbiome dysbiosis and an increased risk of nosocomial infections.

16 Mar 2023

Intensive Care News and Research

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

High-resolution mass spectrometric rapid identification of Candida auris

Study reveals the risk factors associated with developing long Covid

Dampened mucosal response against SARS-CoV-2 in pregnant individuals

End of covid emergency will usher in changes across the US health system

Paxlovid is 80% effective when taken within 5 days of severe COVID

The effectiveness of mRNA vaccines during Omicron BA.4/5 predominance

Co-infection with MRSA ‘superbug’ could make COVID-19 outcomes even more deadly

People conceived by IVF are not at increased risk of obstetric or perinatal complications, study finds

Poor inflammatory immune response in obese patients increases susceptibility to severe COVID-19

Study confirms the benefit of Paxlovid as an early-stage treatment to prevent COVID-19 hospitalization

Real-world data on the effectiveness of Sotrovimab as a prophylactic against COVID-19

Study implicates gut microbiome and immune response in hospital-acquired infections

Maternal opioid treatment after delivery not associated with adverse infant outcomes

The US remains a grim leader in preterm births. Why? And can we fix it?

Premature infants in incubators absorb evaporated alcohol from alcohol-based disinfectants

Experts launch new online resource to support people with Long Covid and improve care

Do the symptom profiles among children with SARS-CoV-2 infection differ by variant type?

The burden of Clostridioides difficile infections in the United States

What are the risk factors associated with post-acute SARS-CoV-2 infection?

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News